Grand Junction and Mesa County · Prescription costs
How Much Is Trelegy on Medicare in Grand Junction for 2027?
Less than it is now. Medicare's negotiated price for a month of Trelegy Ellipta is $175 starting January 1, 2027, 73% below the 2024 list price of $654. Breo Ellipta drops to $67. What you actually pay still depends on your plan's deductible and how it tiers the inhaler, and Mesa County's 2027 plans don't all handle that the same way.
The answer up front
- Trelegy, 2027: $175 for a 30-day supply at Medicare's negotiated price, down from $654.
- Breo, 2027: $67, down from $397.
- Your share on the standard benefit: about $1,050 for a year of Trelegy, or $726 for Breo, if it's your only drug.
- In Mesa County: 6 of the 10 general Advantage drug plans for 2027 set the drug deductible below $700, and all 10 have at least one tier that skips it.
- What to check by December 7: that your 2027 plan covers the inhaler, its tier, and whether that tier waits on the deductible.
Two GSK inhalers get Medicare prices on January 1
In November 2025, CMS announced the second round of prices from the Medicare Drug Price Negotiation Program: 15 drugs, effective January 1, 2027. Two of them are inhalers for asthma and COPD, both made by GSK. They're the only inhalers on the list, in either round.
| Inhaler | Medicare price, 30 days, 2027 | List price, 2024 | Lower by | Part D users, 2024 |
|---|---|---|---|---|
| Trelegy Ellipta | $175 | $654 | 73% | 1,269,000 |
| Breo Ellipta | $67 | $397 | 83% | 626,000 |
Source: CMS, Fact Sheet: Negotiated Prices for Initial Price Applicability Year 2027. CMS also posts a price explanation file for each drug.
Trelegy alone ran $5.3 billion in Part D spending in 2024. CMS says the drug company has to make the negotiated price available to people with Medicare and to the pharmacies that fill it. There's nothing to sign up for. The price is simply what your Medicare drug plan and pharmacy work from in 2027.
What you'd pay, month by month
The negotiated price isn't your copay. It's the price your share is figured from. On the standard Part D benefit for 2027, CMS set a $700 deductible and a $2,400 out-of-pocket cap. Until you meet the deductible, you pay the full drug price. After that you pay 25%. Here's a year of each inhaler on that design, with no other prescriptions:
| Standard benefit, 2027 | Trelegy at $175 | Breo at $67 |
|---|---|---|
| Fills that go toward the $700 deductible | January–April, $175 each | January–October, $67 each |
| Fills after the deductible (25%) | May–December, $43.75 each | November $39.25, December $16.75 |
| Total for the year | $1,050 | $726 |
| Same year at the 2024 list price | $2,400 (the cap, reached in December) | $1,716 |
Our arithmetic from CMS's 2027 negotiated prices and the 2027 standard Part D deductible and cap. Premiums are not included.
The last row is only a yardstick. No one pays exactly list price on a Part D plan today. But it shows where the savings land: in the deductible months and in the 25% that follows. Someone on Trelegy and nothing else would no longer come anywhere near the $2,400 cap.
One honest caveat. Many Advantage plans charge a flat copay for brand-name drugs, say a set dollar amount per fill on the preferred-brand tier, instead of 25%. If that's how your plan prices Trelegy, the copay is the plan's decision, and a lower drug price doesn't automatically change it. Look up the 2027 copay itself, not just the headline price.
On Trelegy or Breo and comparing 2027 plans?
We'll price your inhaler and your other prescriptions on the Mesa County plans we offer, tier by tier, before December 7. Free, at our Grand Junction office or by phone.
Book a call →How Mesa County's 2027 drug plans treat the deductible
Because Trelegy's new price is below the $700 deductible, the deductible decides most of what you pay in the first months of 2027. We pulled the drug deductible for every plan in CMS's CY2027 landscape file for Mesa County.
| Mesa County, 2027 | Drug deductible |
|---|---|
| Aetna Medicare Signature (PPO), Aetna Medicare Value Care (PPO), Aetna Medicare Signature (HMO), HealthSpring True Choice (PPO) | $700 |
| HealthSpring Preferred (HMO) | $500 |
| Humana Essentials Plus Giveback (PPO) | $450 |
| Humana Value Choice (PPO) | $400 |
| Anthem Medicare Advantage (HMO-POS) | $325 |
| Select Health Medicare Essential (HMO), HumanaChoice H5216-223 (PPO) | $300 |
| 8 Colorado stand-alone drug plans (with Original Medicare) | $300 to $700 (five at $700) |
Source: CMS CY2027 landscape, Mesa County, Colorado, general Medicare Advantage plans with drug coverage (special needs plans not shown). Plan names are listed as reporting, not as a recommendation.
Every one of those 10 Advantage plans has at least one drug tier that skips the deductible. That's usually the generic tiers, but not always. So the question for a Trelegy user isn't just "what's the deductible?" It's "is Trelegy on a tier the deductible applies to?" On a plan where the answer is no, you'd pay the plan's copay from your first fill in January. The landscape file doesn't say which tiers are exempt; the plan's 2027 formulary and Evidence of Coverage do.
Why this matters on the Western Slope
The CDC's PLACES county estimates for 2023 put adult asthma in Mesa County at 11.5%, ninth of Colorado's 64 counties. Our neighbors rank higher still: Montezuma County (Cortez) is second in the state at 12.0% and Delta County is sixth at 11.6%, against a state middle of 11.0% and Denver's 10.2%. On COPD, Mesa sits near the middle at 5.8%, while Delta County is tenth at 6.7%.
The spread between counties is small. Still, the inhaler question comes up a lot when we sit down with people in Grand Junction, Fruita and Palisade during Open Enrollment.
A Trelegy checklist before December 7
- Confirm coverage. Make sure your 2027 plan, or the one you're switching to, still lists Trelegy (or Breo). Formularies change every January. Our guide to checking a 2027 plan's drug list walks through it.
- Find the tier and the 2027 cost. Note whether it's a copay or coinsurance, and whether the deductible applies first.
- Price your whole drug list together. The $2,400 cap counts all covered drugs, so a second brand-name prescription changes the math.
- Spread the cost if January is heavy. The Medicare Prescription Payment Plan lets you pay your drug costs in monthly amounts through the year instead of all at the pharmacy counter. It doesn't lower the total.
- If your plan is ending, start with our post on what to do when your drug plan is discontinued.
Other drugs on the negotiation lists work the same way. If you're on Enbrel, our post on Colorado's Enbrel price cap runs that drug's 2027 numbers.
How we know all this: the Medicare On Main Data Desk backs every article with public data. Here that means CMS's fact sheet on 2027 negotiated prices and its selected-drugs page, CMS's 2027 Part D deductible and out-of-pocket cap, the CY2027 Medicare Advantage and Part D landscape file for Mesa County and Colorado, CDC PLACES 2023 county estimates, and Medicare.gov's Prescription Payment Plan page, all read November 22, 2026. Yearly totals are our arithmetic on the standard benefit with one drug and no premium; your plan's design will differ. This is education, not medical or plan advice. Don't change an inhaler without your doctor, and compare plans with a licensed agent or Medicare.gov. We take no payment from any carrier to feature a plan.
Frequently asked questions
Will Trelegy be cheaper on Medicare in 2027?
For most people, yes. Starting January 1, 2027, Medicare's negotiated price for a 30-day Trelegy Ellipta inhaler is $175, down from a 2024 list price of $654. Your share is figured from that lower price, so the deductible and the 25% coinsurance both shrink. If your plan charges a flat copay for Trelegy, the copay is set by the plan and may not change.
How much will Trelegy cost with Medicare in 2027?
On the standard Part D benefit, someone whose only drug is Trelegy pays $175 a fill for four months to meet the $700 deductible, then $43.75 a fill, about $1,050 for the year. Plans with a lower deductible, or a flat copay on Trelegy's tier, can come in under that. The plan premium is extra.
Is Breo Ellipta part of the Medicare price cuts?
Yes. Breo Ellipta's negotiated price is $67 for a 30-day supply starting January 1, 2027, 83% below its 2024 list price of $397. On the standard benefit that works out to about $726 for the year if Breo is your only drug.
Do I have to do anything to get the new Trelegy price?
There's nothing to apply for. The price applies to Medicare drug coverage at the pharmacy. What you do need to check during Open Enrollment, which ends December 7, is that your 2027 plan still covers Trelegy, which tier it's on, and whether that tier is subject to the deductible.
Does Medicare cover albuterol and other inhalers?
Part D plans cover rescue and maintenance inhalers on their formularies, but only Trelegy and Breo got Medicare negotiated prices for 2027. Every other inhaler is priced by your plan as usual. All covered drugs count toward the $2,400 out-of-pocket cap for 2027.
Sources
- CMS — Fact sheet: Negotiated prices for initial price applicability year 2027 (PDF)
- CMS — Selected drugs and negotiated prices (Medicare Drug Price Negotiation Program)
- CMS — 2027 Announcement of Medicare Advantage and Part D payment policies (Part D deductible $700, out-of-pocket threshold $2,400)
- CMS — CY2027 Medicare Advantage and Part D landscape files (September 2026, ZIP)
- CDC PLACES — County data, 2025 release (CASTHMA, COPD)
- Medicare.gov — Medicare Prescription Payment Plan